Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Ebola Infection”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)Study completedNCT02503202
What this trial is testing

Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)

Who this might be right for
Prevention of Ebola Infection
Merck Sharp & Dohme LLC 1,197
Early research (Phase 1)Study completedNCT01353027
What this trial is testing

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Post-approval studies (Phase 4)Study completedNCT03072030
What this trial is testing

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Who this might be right for
Ebola Virus DiseasePrevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 2,000
Early research (Phase 1)UnknownNCT04717830
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)Study completedNCT03428347
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

Who this might be right for
Healthy
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Testing effectiveness (Phase 2)UnknownNCT04822376
What this trial is testing

Prophylaxis Vaccine Antibodies Ebola

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 250
Testing effectiveness (Phase 2)Study completedNCT02788227
What this trial is testing

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 99
Large-scale testing (Phase 3)Not Yet RecruitingNCT05959421
What this trial is testing

Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure

Who this might be right for
Ebola Vaccine
Universitätsklinikum Hamburg-Eppendorf 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841614
What this trial is testing

EBOla Post-Exposure Prophylaxis

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 160
Early research (Phase 1)Study completedNCT00374309
What this trial is testing

Experimental Vaccine for Prevention of Ebola Virus Infection

Who this might be right for
Ebola Hemorrhagic FeverEbola Virus DiseaseEbola Virus Vaccines+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)WithdrawnNCT04268966
What this trial is testing

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

Who this might be right for
Ebola Virus Disease
Jazz Pharmaceuticals
Not applicableAvailableNCT05067166
What this trial is testing

Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP

Who this might be right for
Ebola Virus Disease
Ridgeback Biotherapeutics, LP
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05202288
What this trial is testing

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 132